首页> 外文期刊>Chest >Comparison of the Effects of Nitric Oxide, Nitroprusside, and Nifedipine on Hemodynamics and Right Ventricular Contractility in Patients With Chronic Pulmonary Hypertension*
【24h】

Comparison of the Effects of Nitric Oxide, Nitroprusside, and Nifedipine on Hemodynamics and Right Ventricular Contractility in Patients With Chronic Pulmonary Hypertension*

机译:一氧化氮,硝普钠和硝苯地平对慢性肺动脉高压患者血流动力学和右心室收缩的影响比较*

获取原文
获取原文并翻译 | 示例
           

摘要

Study objectives: The effects of inhaled nitric oxide (NO) on hemodynamics and right ventricularn(RV) contractility were compared with those of nitroprusside and nifedipine in 14 patients withnsevere chronic pulmonary hypertension.nStudy design: Micromanometer and balloon-tipped right heart catheterization were performed.nInhaled NO, IV nitroprusside, and sublingual nifedipine were administered sequentially whilenpatients breathed > 90% oxygen.nSetting: Cardiac catheterization laboratory in a tertiary care teaching hospital.nPatients: Fourteen patients with severe pulmonary hypertension unrelated to left ventricular dysfunction.nMeasurements and results:During NO inhalation, mean systemic arterial pressure (MAP) was unchanged,nbut pulmonary artery (PA) pressure ([mean 6SEM] 4962mmHgvs4462mmHg;p<0.01),npulmonary vascular resistance (PVR; 829668 vs 669664 dyne z s z cm25n;p<0.01) and RV end-diastolicnpressure (RVEDP; 1261vs1061 mm Hg; p<0.01) decreased. Stroke volume index (SVI; 3162vsn3563mL/m2n;p<0.05) increased, and the first derivative of RV pressure at 15 mm Hg developednpressure (RV 1dP/dt at DP15) was unchanged. During nitroprusside administration, MAP decreasedn(10565vs7665mmHg;p<0.01), PA was unchanged (4862vs4563mmHg;p5 not significant),nand PVR decreased (791653 vs 665653 dyne z s z cm25n;p<0.01). RV 1dP/dt at DP15 increasedn(425622 vs 465629 mm Hg/s; p < 0.05), but SVI was unchanged. Nifedipine decreased MAPn(103 6 5vs94 6 5mmHg;p < 0.01), PA and PVR were unchanged, RVEDP increased (12 6 1vsn14 6 2mmHg;p < 0.01), and RV 1dP/dt at DP15 decreased (432 6 90 vs 389 6 21 mm Hg/s;np < 0.05).nConclusions: Inhaled NO is a selective pulmonary vasodilator in patients with chronic pulmonarynhypertension that improves cardiac performance without altering RV contractility. Nitroprusside causedna similar degree of pulmonary vasodilation. In contrast to inhaled NO, nitroprusside caused systemicnhypotension associated with an increase in RV contractility. Acute administration of nifedipine did notncause pulmonary vasodilation, but RVEDP increased and RV contractility decreased..
机译:研究目的:比较14例轻度慢性肺动脉高压患者中一氧化氮(NO)吸入对血流动力学和右心室(RV)收缩力的影响。研究设计:显微压力计和右端气囊球囊扩张术n当患者呼吸的氧气> 90%时,依次吸入NO,IV硝普钠和舌下硝苯地平n设置:三级教学医院的心脏导管实验室n患者:14例与左心功能不相关的严重肺动脉高压患者。测量和结果:吸入NO时,平均全身动脉压(MAP)不变,但肺动脉(PA)压([平均值6SEM] 4962mmHgvs4462mmHg; p <0.01),肺血管阻力(PVR; 829668 vs 669664达因zsz cm25n; p <0.01) RV舒张末期压力(RVEDP; 1261vs1061 mm Hg; p <0.01)降低。卒中体积指数(SVI; 3162vsn3563mL / m2n; p <0.05)增加,并且在15 mm Hg显影压力下的RV压力的一阶导数(在DP15处的RV 1dP / dt)不变。在硝普钠给药期间,MAP降低(10565vs7665mmHg; p <0.01),PA不变(4862vs4563mmHg; p5不显着),PVR降低(791653 vs 665653达因z s cm25n; p <0.01)。 DP15的RV 1dP / dt增加了(425622 vs 465629 mm Hg / s; p <0.05),但SVI不变。硝苯地平降低MAPn(103 6 5vs94 6 5mmHg; p <0.01),PA和PVR不变,RVEDP增加(12 6 1vsn14 6 2mmHg; p <0.01),DP15的RV 1dP / dt降低(432 6 90 vs 389 6) 21 mm Hg / s; np <0.05)。n结论:吸入性NO是慢性肺动脉高压患者的一种选择性肺血管扩张剂,可改善心脏功能而不改变RV收缩力。硝普钠引起相似程度的肺血管扩张。与吸入NO相比,硝普钠可引起全身性低血压,并伴有RV收缩力增加。硝苯地平的急性给药并未引起肺血管舒张,但RVEDP升高而RV收缩力降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号